National and regional differences in meningococcal vaccine recommendations for individuals at an increased risk of meningococcal disease
Introduction Invasive meningococcal disease (IMD) is a severe, life-threatening condition caused by infection with Neisseria meningitidis. Currently available vaccines offer protection against the five most common meningococcal disease-causing serogroups and include monovalent and quadrivalent conju...
Main Authors: | Cynthia Burman, Jamie Findlow, Helen S. Marshall, Marco A.P. Safadi |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2023-12-01
|
Series: | Expert Review of Vaccines |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/14760584.2023.2245467 |
Similar Items
-
Overview of meningococcal epidemiology and national immunization programs in children and adolescents in 8 Western European countries
by: Gaëlle Pinto Cardoso, et al.
Published: (2022-11-01) -
Immunogenicity and safety of MenACWY-TT, a quadrivalent meningococcal tetanus toxoid conjugate vaccine recently licensed in the United States for individuals ≥2 years of age
by: Gary S. Marshall, et al.
Published: (2022-11-01) -
Determinants of Meningococcal Vaccination Coverage and Adherence: A Targeted Literature Review Supporting a 16-year-old Healthcare Visit
by: Oscar Herrera-Restrepo, et al.
Published: (2023-05-01) -
Meningococcal serogroup B vaccine: Knowledge and acceptability among parents in Italy
by: Teresa Morrone, et al.
Published: (2017-08-01) -
Survey among Italian experts on existing vaccines’ role in limiting antibiotic resistance
by: Federico Marchetti, et al.
Published: (2021-11-01)